These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

732 related items for PubMed ID: 15915369

  • 1. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y, Kitajima Y, Miyoshi A, Sato K, Kitahara K, Soejima H, Miyazaki K.
    Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
    [Abstract] [Full Text] [Related]

  • 2. Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations.
    Kim JI, Suh JT, Choi KU, Kang HJ, Shin DH, Lee IS, Moon TY, Kim WT.
    Hum Pathol; 2009 Jul; 40(7):934-41. PubMed ID: 19356788
    [Abstract] [Full Text] [Related]

  • 3. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.
    Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, Issa JP, Sidransky D, Baylin SB, Herman JG.
    Cancer Res; 2000 May 01; 60(9):2368-71. PubMed ID: 10811111
    [Abstract] [Full Text] [Related]

  • 4. O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions.
    Halford S, Rowan A, Sawyer E, Talbot I, Tomlinson I.
    Gut; 2005 Jun 01; 54(6):797-802. PubMed ID: 15888787
    [Abstract] [Full Text] [Related]

  • 5. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.
    Clin Cancer Res; 2005 Aug 01; 11(15):5365-9. PubMed ID: 16061849
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
    Zuo C, Ai L, Ratliff P, Suen JY, Hanna E, Brent TP, Fan CY.
    Cancer Epidemiol Biomarkers Prev; 2004 Jun 01; 13(6):967-75. PubMed ID: 15184253
    [Abstract] [Full Text] [Related]

  • 8. O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer.
    Wolf P, Hu YC, Doffek K, Sidransky D, Ahrendt SA.
    Cancer Res; 2001 Nov 15; 61(22):8113-7. PubMed ID: 11719438
    [Abstract] [Full Text] [Related]

  • 9. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis.
    Esteller M, Risques RA, Toyota M, Capella G, Moreno V, Peinado MA, Baylin SB, Herman JG.
    Cancer Res; 2001 Jun 15; 61(12):4689-92. PubMed ID: 11406538
    [Abstract] [Full Text] [Related]

  • 10. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.
    Gilliland FD, Harms HJ, Crowell RE, Li YF, Willink R, Belinsky SA.
    Cancer Res; 2002 Apr 15; 62(8):2248-52. PubMed ID: 11956078
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
    Schildhaus HU, Kröckel I, Lippert H, Malfertheiner P, Roessner A, Schneider-Stock R.
    Int J Oncol; 2005 Jun 15; 26(6):1493-500. PubMed ID: 15870861
    [Abstract] [Full Text] [Related]

  • 13. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.
    Pulling LC, Divine KK, Klinge DM, Gilliland FD, Kang T, Schwartz AG, Bocklage TJ, Belinsky SA.
    Cancer Res; 2003 Aug 15; 63(16):4842-8. PubMed ID: 12941804
    [Abstract] [Full Text] [Related]

  • 14. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
    Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD.
    Cancer Res; 2001 Jan 01; 61(1):249-55. PubMed ID: 11196170
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa.
    Herath NI, Walsh MD, Kew M, Smith JL, Jass JR, Young J, Leggett BA, Macdonald GA.
    Oncol Rep; 2007 Apr 01; 17(4):817-22. PubMed ID: 17342321
    [Abstract] [Full Text] [Related]

  • 17. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
    Chan EC, Lam SY, Tsang KW, Lam B, Ho JC, Fu KH, Lam WK, Kwong YL.
    Clin Cancer Res; 2002 Dec 01; 8(12):3741-6. PubMed ID: 12473584
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.